NF1 and neoplasm: Still, other genetic aberrations such as TP53 loss, ATRX mutations, CDKN2A/B homozygous loss or mutation, PIK3CA or PIK3R1 mutation, SUZ12 deletion, as well as the NF1 haploinsufficient environment and immune system, are drivers for tumor development.